CLINICAL_TRIALS
trial_result
· 2012-05-15
Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients [Phase 3]
Summary
A Phase 3 trial evaluated the efficacy and safety of quetiapine fumarate in patients with schizophrenia; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-05-15